News + Filings Transactions Holdings
All 13F 13D/G Other
|
DUGGAN ROBERT W
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/10/2023 |
SC 13D/A
| DUGGAN ROBERT W reports a 68.7% stake in Pulse Biosciences, Inc. |
12/09/2022 |
SC 13D/A
| DUGGAN ROBERT W reports a 81.8% stake in Summit Therapeutics Inc. |
08/18/2022 |
SC 13D/A
| DUGGAN ROBERT W reports a 81.2% stake in Summit Therapeutics Inc. |
06/10/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/02/2021 |
SC 13D/A
| DUGGAN ROBERT W reports a 51.2% stake in Pulse Biosciences, Inc. |
05/14/2021 |
SC 13D/A
| DUGGAN ROBERT W reports a 70.8% stake in Summit Therapeutics Inc. |
05/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/22/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
03/26/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
11/10/2020 |
SC 13D/A
| DUGGAN ROBERT W reports a 69.9% stake in Summit Therapeutics Inc. |
10/06/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/17/2020 |
SC 13D/A
| DUGGAN ROBERT W reports a 47.2% stake in Pulse Biosciences, Inc. |
01/16/2020 |
SC 13D/A
| DUGGAN ROBERT W reports a 64.9% stake in Summit Therapeutics PLC |
12/27/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/10/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/12/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/05/2019 |
SC 13D/A
| DUGGAN ROBERT W reports a 5.3% stake in Achaogen, Inc. |
03/28/2019 |
SC 13D/A
| DUGGAN ROBERT W reports a 6.8% stake in Achaogen, Inc. |
03/20/2019 |
SC 13D/A
| DUGGAN ROBERT W reports a 9.1% stake in Achaogen, Inc. |
03/13/2019 |
SC 13D/A
| DUGGAN ROBERT W reports a 11.1% stake in Achaogen, Inc. |
02/26/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/18/2019 |
SC 13D/A
| DUGGAN ROBERT W reports a 5% stake in Aurinia Pharmaceuticals Inc. |
12/17/2018 |
SC 13D/A
| DUGGAN ROBERT W reports a 44% stake in Pulse Biosciences, Inc. |
12/12/2018 |
SC 13D/A
| DUGGAN ROBERT W reports a 20.4% stake in Achaogen, Inc. |
05/07/2018 |
SC 13D/A
| DUGGAN ROBERT W reports a 18.4% stake in Achaogen, Inc. |
04/23/2018 |
SC 13D/A
| DUGGAN ROBERT W reports a 15.7% stake in Achaogen, Inc. |
12/08/2017 |
SC 13D/A
| DUGGAN ROBERT W reports a 13.2% stake in Achaogen, Inc. |
10/23/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
10/19/2017 |
SC 13D/A
| DUGGAN ROBERT W reports a 7.3% stake in Achaogen, Inc. |
09/26/2017 |
SC 13D/A
| DUGGAN ROBERT W reports a 35.7% stake in Pulse Biosciences, Inc. |
09/18/2017 |
SC 13D/A
| DUGGAN ROBERT W reports a 26.7% stake in Pulse Biosciences, Inc. |
08/03/2017 |
SC 13D/A
| DUGGAN ROBERT W reports a 23.9% stake in Pulse Biosciences, Inc. |
05/11/2017 |
SC 13D/A
| DUGGAN ROBERT W reports a 21.6% stake in Pulse Biosciences, Inc. |
04/19/2017 |
SC 13D/A
| Pulse Biosciences, Inc. reports a 20.4% stake in Pulse Biosciences, Inc. |
|
|
|